Evidence map›Paper›PMID 36087218›Full record

Observational studyJournal of nephrology2023

Sex differences in COVID-19 symptoms and outcomes in people with kidney failure treated with dialysis: a prospective cohort study.

Tyrone G Harrison, Trinity A Tam, Meghan J Elliott, Sofia B Ahmed, Victoria Riehl-Tonn, Asha K R Swamy, Jamie L Benham, Joanne Peterson, Jennifer M MacRae

Open access · bronzeAbstract readObservational Study
In one paragraph

Observational study in Journal of nephrology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Tyrone G HarrisonDepartment of Medicine, University of Calgary, Calgary, AB, Canada.ORCID http://orcid.org/0000-0003-1068-8673
Trinity A TamDepartment of Medicine, University of Calgary, Calgary, AB, Canada.
Meghan J ElliottDepartment of Medicine, University of Calgary, Calgary, AB, Canada.
Sofia B AhmedDepartment of Medicine, University of Calgary, Calgary, AB, Canada.
Victoria Riehl-TonnDepartment of Medicine, University of Calgary, Calgary, AB, Canada.
Asha K R SwamyDepartment of Medicine, University of Calgary, Calgary, AB, Canada.
Jamie L BenhamDepartment of Medicine, University of Calgary, Calgary, AB, Canada.
Joanne PetersonAlberta Health Services, Alberta, Canada.
Jennifer M MacRaeDepartment of Medicine, University of Calgary, Calgary, AB, Canada. jmmacrae@ucalgary.ca.
University of Calgary · CAAlberta Health Services · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPeople with kidney failure treated with dialysis are at increased risk of SARS-CoV-2 infection, and severe COVID-19 outcomes such as hospitalization and death. Though there are well-defined sex differences in outcomes for the general population with COVID-19, we do not know whether this translates into kidney failure populations. We aimed to estimate the differences in COVID-19 symptoms and clinical outcomes between males and females treated with maintenance dialysis.

methodsIn this prospective observational cohort study, we included adults treated with maintenance dialysis in Southern Alberta, Canada that tested positive for COVID-19 between March 2020 and February 2022. We examined the association between sex (dichotomized as male and female) with COVID-19 symptoms including fever, cough, malaise, shortness of breath, muscle joints/aches, nausea and/or vomiting, loss of appetite, diarrhea, headache, sore throat, and loss of smell/taste using chi-square or Fisher's exact tests. Secondary outcomes included 30-day hospitalization, ICU admission, and death.

resultsOf 1,329 cohort participants, 246 (18.5%) tested positive for SARS-CoV-2 and were included in our study, including 95 females (39%). Of 207 participants with symptoms assessed, females had less frequent fever (p = 0.003), and more nausea or vomiting (p = 0.003) compared to males, after correction for multiple testing. Males exhibited no symptoms 25% of the time, compared with 10% of females (p = 0.01, not significant when corrected for multiple testing). We did not identify statistically significant differences in clinical outcomes between the sexes, though vaccinated patients had lower odds of hospitalization.

conclusionsSex differences in COVID-19 symptoms were identified in a cohort of patients treated with maintenance dialysis, which may inform sex-specific screening strategies in dialysis units. Further work is necessary to examine mechanisms for identified sex differences.

Indexed as

COVID-19Renal InsufficiencyAdultAlbertaFemaleHumansMaleProspective StudiesRenal DialysisSARS-CoV-2Sex CharacteristicsCOVID-19DialysisKidney failureSARS-CoV-2Sex

Identifiers

PMID36087218
PMCPMC9463668
OpenAlexW4295511534

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.